Mei, Y., Chen, M. M., Liang, H., & Ma, L. (2021). A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma. Nature Portfolio.
Cita Chicago Style (17a ed.)Mei, Ying, Mei-Ju May Chen, Han Liang, y Li Ma. A Four-gene Signature Predicts Survival and Anti-CTLA4 Immunotherapeutic Responses Based on Immune Classification of Melanoma. Nature Portfolio, 2021.
Cita MLA (8a ed.)Mei, Ying, et al. A Four-gene Signature Predicts Survival and Anti-CTLA4 Immunotherapeutic Responses Based on Immune Classification of Melanoma. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.